Submitted by Anonymous (not verified) on 13 November 2023 - 12:03
Opinion/decision on a Paediatric investigation plan (PIP): dolutegravir,HIV-1 Maturation Inhibitor (GSK3640254), decision type: , therapeutic area: , PIP number: P/0523/2022
Source: